Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-09-04Evaluating Immune Response to Seasonal FluMist in Healthy Adults
-
CLINICAL_TRIALS study record update · 2014-08-22Immune Responses in Preterm and Full-Term Infants Following Live, Attenuated Influenza Vaccination
-
CLINICAL_TRIALS study record update · 2014-08-22Prospective Study to Evaluate Viral Shedding Patterns and Clinical Outcomes of Hospitalized Adult Influenza Patients
-
CLINICAL_TRIALS study record update · 2014-08-20A Phase I, Open Label, Randomized Study in Healthy Adults to Compare Safety and Immunogenicity of Different Administration Schedules of Virosomal Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2014-08-13A Randomized, Open-label (Part A) or Double-blind (Part B), Active-controlled (Part B) Phase I/IIa Study to Investigate the Safety, Tolerability, and Immunogenicity of GC3110A (Quadrivalent Influenza Vaccine)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-08-06Oseltamivir Treatment in Children Under One Year of Age With Moderate or Severe Influenza Lower Respiratory Tract Infection - a Clinical and Pharmacokinetic Study
-
CLINICAL_TRIALS study record update · 2014-08-06Efficacy Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults
-
CLINICAL_TRIALS study record update · 2014-07-14Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Quadrivalent Seasonal Influenza Candidate Vaccine GSK2321138A, Administered to Children Who Previously Participated in Study 115345
-
CLINICAL_TRIALS study record update · 2014-07-01Efficacy of Early Oseltamivir Phosphate Treatment at Hospital Admission to Reduce Severity of Illness Among Children Aged Less Than 10 Years Hospitalized With Influenza in El Salvador and Panama
-
CLINICAL_TRIALS study record update · 2014-06-26The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate and Morbidity in Infants Born Premature.
-
CLINICAL_TRIALS study record update · 2014-06-24FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record
-
CLINICAL_TRIALS study record update · 2014-06-24Pilot Study of Text Message Reminders for Flu Vaccine For Adults
-
CLINICAL_TRIALS study record update · 2014-06-12A Phase III, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity and the Consistency of Three Consecutive Lots of a MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects Aged 65 Years and Older
-
CLINICAL_TRIALS study record update · 2014-06-03Evaluation of Heterosubtypic Immune Responses in Older People Before and After Seasonal and Pandemic Influenza Vaccination
-
CLINICAL_TRIALS study record update · 2014-06-03A Randomized, Partially Observer-blind, Single-centre Study to Evaluate Safety and Immunogenicity of MF59-adjuvanted or Non-adjuvanted H5N1 Influenza Vaccines in Adults Primed With Adjuvanted Influenza A/Vietnam/1194/04 (H5N1) Vaccine
-
CLINICAL_TRIALS study record update · 2014-06-03A Phase II, Randomized, Open, Controlled Study to Evaluate the Safety and Immunogenicity of Different Formulations of a Pandemic Influenza Vaccine Candidate (Split Virus Formulation Adjuvanted With AS03) Given Following a Two-administration Schedule (21 Days Apart) in Children Between 3 and 9 Years of Age.
-
CLINICAL_TRIALS study record update · 2014-06-02Impact of Video Education on Influenza Vaccination Rate in Pregnancy
-
CLINICAL_TRIALS study record update · 2014-05-22High-Dose Versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza: A Phase II Double-Blind, Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2014-05-16A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
-
CLINICAL_TRIALS study record update · 2014-05-16A Phase II Study in Adults With Rheumatoid Arthritis Receiving TNF-alpha-inhibitor Therapy to Assess the Immunogenicity and Safety of Trivalent Inactivated Vaccine (TIV) and High Dose Trivalent Inactivated Vaccine (High-Dose TIV) Administered at Two Dosage Levels
-
CLINICAL_TRIALS study record update · 2014-05-14Collection & Extraction of Respiratory Specimens for the Validation of the Artus Influenza RG PCR Test
-
CLINICAL_TRIALS study record update · 2014-05-13A Phase II Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers.
-
CLINICAL_TRIALS study record update · 2014-05-12Phase 4 Study of Post-License Safety Evaluation of Influenza Split Vaccine
-
CLINICAL_TRIALS study record update · 2014-05-08A Post-marketing Safety Study of SIBP's Inactivated, Split-virion Influenza Vaccine Administered in Chinese Subjects Aged 3 Years and Older
-
CLINICAL_TRIALS study record update · 2014-04-30Clinical Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B in the Primary Health Setting